SELECTIVITY AND THE DESIGN OF HISTAMINE H₂-RECEPTOR ANTAGONISTS.GANELLIN CR.1978; J. APPL. CHEM. BIOTECHNOL.; G.B.; DA. 1978; VOL. 28; NO 3; PP. 183-200; BIBL. 33 REF.Article

RELATIVE CONCENTRATIONS OF ZWITTERIONIC AND UNCHARGED SPECIES IN CATECHOLAMINES AND THE EFFECT OF N-SUBSTITUENTS.GANELLIN CR.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 4; PP. 579-581; BIBL. 7 REF.Article

CONFORMATION OF HISTAMINE DERIVATIVES. III. A RELATIONSHIP BETWEEN CONFORMATION AND PHARMACOLOGICAL ACTIVITYGANELLIN CR.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 6; PP. 620-623; BIBL. 11REF.Serial Issue

THE PRESSOR ACTIVITY OF BURIMAMIDE: A RELATIONSHIP BETWEEN CHEMICAL CONSTITUTION AND PRESSOR ACTIVITY OF BURIMAMIDE AND RELATED HISTAMINE H₂-RECEPTOR ANTAGONISTS.GANELLIN CR; OWEN DAA.1977; AGENTS AND ACTIONS; SWITZ.; DA. 1977; VOL. 7; NO 1; PP. 93-96; BIBL. 9 REF.Article

CONFORMATION OF HISTAMINE DERIVATIVES. II. MOLECULAR ORBITAL CALCULATIONS OF PREFERRED CONFORMATIONS IN RELATION TO DUAL RECEPTOR ACTIVITYGANELLIN CR; PORT GNJ; RICHARDS WG et al.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 6; PP. 616-620; BIBL. 5REF.Serial Issue

IMIDAZOLE GEOMETRY AND THE CALCULATION OF TAUTOMER PREFERENCE FOR HISTAMINERICHARDS WG; WALLIS J; GANELLIN CR et al.1979; EUROP. J. MEDICIN. CHEM.; FRA; DA. 1979; VOL. 14; NO 1; PP. 9-12; ABS. FRE/GER; BIBL. 23 REF.Article

DIMAPRIT, S-3-(N,N-DIMETHYLAMINO) PROPYL ISOTHIOUREA. A HIGHLY SPECIFIC HISTAMINE H₂-RECEPTOR AGONIST. II. STRUCTURE-ACTIVITY CONSIDERATIONS.DURANT GJ; GANELLIN CR; PARSONS ME et al.1977; AGENTS AND ACTIONS; SWITZ.; DA. 1977; VOL. 7; NO 1; PP. 39-43; BIBL. 16 REF.Article

CHEMICAL DIFFERENTIATION OF HISTAMINE H₁- AND H₂-RECEPTOR AGONISTSDURANT GJ; GANELLIN CR; PARSONS ME et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 9; PP. 905-909; BIBL. 31 REF.Article

2-(4-IMIDAZOLYL) ETHYLAMMONIUM BROMIDE (HISTAMINE MONOHYDROBROMIDE).PROUT K; CRITCHLEY SR; GANELLIN CR et al.1974; ACTA CRYSTALLOGR., B; DANEM.; DA. 1974; VOL. 30; NO 12; PP. 2884-2886; BIBL. 21 REF.Article

HISTAMINE-INDUCED INHIBITION OF LYMPHOCYTE PROLIFERATION AND LYSOSOMAL ENZYME RELEASE FROM POLYMORPHS MAY NOT BE MEDIATED VIA H₁- OR H₂-RECEPTORSVICKERS MR; MILLINER K; MARTIN D et al.1982; AGENTS AND ACTIONS; ISSN 0538-4818; CHE; DA. 1982; VOL. 12; NO 5-6; PP. 630-634; BIBL. 26 REF.Article

SELECTIVE IMPAIRMENT OF ATRIOVENTRICULAR CONDUCTION BY 2-(2-PYRIDYL)-ETHYLAMINE AND 2-(2-THIAZOLYL)-ETHYLAMINE, TWO HISTAMINE H₁-RECEPTOR AGONISTS.LEVI R; GANELLIN CR; ALLAN G et al.1975; EUROP. J. PHARMACOL.; NETHERL.; DA. 1975; VOL. 34; NO 1; PP. 237-240; BIBL. 9 REF.Article

BINDING OF (³H) CIMETIDINE TO RAT BRAIN TISSUESMITH IR; CLEVERLEY MT; GANELLIN CR et al.1980; AGENTS & ACTIONS; ISSN 0538-4818; CHE; DA. 1980; VOL. 10; NO 5; PP. 423-426; BIBL. 22 REF.Article

CRYSTAL AND MOLECULAR STRUCTURE OF THE HISTAMINE H₂-RECEPTOR ANTAGONISTS, N-METHYL-N'-(2-((5-METHYLIMIDAZOL-4-YL)METHYLTHIO)ETHYL)THIOUREA (METHIAMIDE) AND N-(2-(IMIDAZOL-4-YL)METHYLTHIO)ETHYL)-N'-METHYLTHIOUREA(THIABURIMAMIDE ).PROUT K; CRITCHLEY SR; GANELLIN CR et al.1977; J. CHEM. SOC., PERKIN TRANS., 2; G.B.; DA. 1977; NO 1; PP. 68-75; BIBL. 19 REF.Article

DIMAPRIT-(S-(3-(N,N-DIMETHYLAMINO) PROPYL) ISOTHIOUREA) - A HIGHLY SPECIFIC HISTAMINE H₂-RECEPTOR AGONIST. I. PHARMACOLOGY.PARSONS ME; OWEN DAA; GANELLIN CR et al.1977; AGENTS AND ACTIONS; SWITZ.; DA. 1977; VOL. 7; NO 1; PP. 31-37; BIBL. 20 REF.Article

THE DIPOLE MOMENTS OF 1,3-DIMETHYLTHIOUREA, 1,3-DIMETHYL-2-CYANOGUANIDINE AND 1,1-BIS-METHYLAMINO-2-NITROETHENE IN AQUEOUS SOLUTIONYOUNG RC; GANELLIN CR; GRAHAM MJ et al.1982; TETRAHEDRON; ISSN 0040-4020; GBR; DA. 1982; VOL. 38; NO 10; PP. 1493-1497; BIBL. 29 REF.Article

POTENTIAL HISTAMINE H₂-RECEPTOR ANTAGONISTS. IV: BENZYLHISTAMINESEMMETT JC; DURANT GJ; GANELLIN CR et al.1982; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1982; VOL. 25; NO 10; PP. 1168-1174; BIBL. 30 REF.Article

POTENTIAL HISTAMINE H₂-RECEPTOR ANTAGONISTS. III. METHYLHISTAMINES.DURANT GJ; EMMETT JC; GANELLIN CR et al.1976; J. MEDICIN. CHEM.; U.S.A.; DA. 1976; VOL. 19; NO 7; PP. 923-928; BIBL. 46 REF.Article

CONFORMATION OF HISTAMINE DERIVATIVES. I. APPLICATION OF MOLECULAR ORBITAL CALCULATIONS AND NUCLEAR MAGNETIC RESONANCE SPECTROSCOPYGANELLIN CR; PEPPER ES; PORT GNJ et al.1973; J. MEDICIN CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 6; PP. 610-616; BIBL. 26REF.Serial Issue

CYANOGUANIDINE-THIOUREA EQUIVALENCE IN THE DEVELOPMENT OF THE HISTAMINE H₂-RECEPTOR ANTAGONIST, CIMETIDINE.DURANT GJ; EMMETT JC; GANELLIN CR et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 7; PP. 901-906; BIBL. 51 REF.Article

CIMETIDINE-A NON-THIOUREA H₂-RECEPTOR ANTAGONIST = LA CIMETIDINE, UN ANTAGONISTE NON THIOUREE DES RECEPTEURS H₂BRIMBLECOMBE RW; DUNCAN WAM; DURANT GJ et al.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 2; PP. 86-92; BIBL. 11REF.Article